TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
INDP

Indaptus Therapeutics Inc

Healthcare · Biotechnology

3.20$ +0.6% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Indaptus Therapeutics Inc (INDP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 29.5% of the shares are freely tradable; institutional investors hold 0.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 0.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 97.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 29.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 133Mio.

Largest Shareholders

Institutions

Institutions INDP
Name Stake (%) Shares Change (%) Date
HRT FINANCIAL LLC 0.15 206,077 +0.0 06/30/2026
Geode Capital Management, LLC 0.04 56,470 +109.1 06/30/2026
Jane Street Group LLC 0.04 53,811 +0.0 06/30/2026
Vanguard Capital Management, LLC 0.03 33,652 +0.0 06/30/2026
Vanguard Fiduciary Trust Co 0.01 13,967 +0.0 06/30/2026
Millennium Management LLC 0.01 11,586 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 0.01 8,936 +231.3 06/30/2026

Funds

Funds INDP
Name Stake (%) Shares Change (%) Date
Fidelity Nasdaq Composite Index 0.05 69,403 +0.0 08/31/2026
Fidelity Extended Market Index 0.04 57,460 +400.8 09/30/2026
Fidelity Series Total Market Index 0.02 20,389 +418.9 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?